Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut

Repligen Beats on Q3 Earnings & Sales, Narrows '24 Sales View

Here's Why Biogen Inc. (BIIB) is a Strong Value Stock

Is Eli Lilly Stock A Sell After Its Disastrous Third-Quarter Report?

Perrigo's Q3 Earnings Fall Short of Estimates, Sales View Updated

BIIB vs. MYGN: Which Stock Is the Better Value Option?

Are Investors Undervaluing Biogen (BIIB) Right Now?

Biogen (BIIB) Loses -6.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Biogen Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Biogen down as Morgan Stanley cuts rating on sluggish Alzheimer’s drug launch

Biogen Inc (BIIB) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference